Skip to main content
Equibles

VANGUARD ASSET MANAGEMENT, Ltd

Position in NVCR — NovoCure Ltd

CIK 1680208 London, EC4N 8AF, X0
Back to NVCR Full portfolio

Position in NVCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,477,640
+$414,520 QoQ
Shares Held
97,534
0.0% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 217 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

VANGUARD ASSET MANAGEMENT, Ltd holds $1,296,085,735 across 41 Medical Devices names. NVCR ranks #23 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 3,921,702 $355,855,239
2 MDT
Medtronic plc
 2,891,131 $226,173,178
3 SYK
Stryker Corp
 674,424 $212,335,652
4 BSX
Boston Scientific Corp
 2,873,191 $122,627,791
5 EW
Edwards Lifesciences Corp
 1,111,236 $100,522,408
6 GEHC
GE HealthCare Technologies Inc.
 881,507 $56,425,263
7 DXCM
Dexcom Inc
 741,928 $49,968,850
8 STE
STERIS plc
 191,300 $40,282,041

All Filings in NVCR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,477,640 97,534
2026-03-31 $1,063,120 97,534